FDA label 41ae2b5a-6dd6-7677-e063-6394a90aed0b

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
c164269b-d3e8-602f-e053-2995a90abe24
SPL ID
41ae2b5a-6dd6-7677-e063-6394a90aed0b
Version
6
Effective date
2025-10-21
Source export date
2026-11-06
Source partition
12
Source file
https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-06/39f3c0903357a80632a5484c9d6a804272f4b297080aa9c5a01a84db133f7a03/drug-label-0012-of-0014.json.zip
Source manifest SHA-256
4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run
20261108T063105Z
Imported at
2026-11-08 08:04:21

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. FemiClear is not a cure for herpes and will not prevent future outbreaks. This product will not stop the spread of herpes viruses or other viruses. Viral infections are contagious. FemiClear does not prevent sexually transmitted infections (STIs). Practice safer sex by using latex or polyurethane condom to reduce risk of getting STIs. FemiClear may damage condoms and diaphragms and cause ethem to fail

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.